9258 Wealth Management LLC Takes Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

9258 Wealth Management LLC bought a new position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report) during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor bought 5,690 shares of the medical instruments supplier’s stock, valued at approximately $203,000.

Other hedge funds also recently added to or reduced their stakes in the company. VisionPoint Advisory Group LLC increased its position in shares of DENTSPLY SIRONA by 104.2% during the third quarter. VisionPoint Advisory Group LLC now owns 774 shares of the medical instruments supplier’s stock worth $26,000 after acquiring an additional 395 shares during the period. Headlands Technologies LLC purchased a new stake in DENTSPLY SIRONA during the 4th quarter worth about $30,000. Parkside Financial Bank & Trust raised its position in DENTSPLY SIRONA by 33.3% in the 4th quarter. Parkside Financial Bank & Trust now owns 1,169 shares of the medical instruments supplier’s stock valued at $42,000 after purchasing an additional 292 shares in the last quarter. Anchor Investment Management LLC purchased a new position in shares of DENTSPLY SIRONA in the 4th quarter valued at about $47,000. Finally, GAMMA Investing LLC acquired a new position in shares of DENTSPLY SIRONA during the fourth quarter worth about $55,000. 95.70% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on XRAY shares. Piper Sandler reiterated a “neutral” rating and issued a $32.00 price target (down previously from $35.00) on shares of DENTSPLY SIRONA in a research note on Friday, May 3rd. The Goldman Sachs Group dropped their target price on DENTSPLY SIRONA from $34.00 to $30.00 and set a “neutral” rating on the stock in a report on Monday, May 6th. Needham & Company LLC lowered their price objective on DENTSPLY SIRONA from $42.00 to $36.00 and set a “buy” rating for the company in a research report on Friday, May 3rd. Robert W. Baird dropped their price objective on DENTSPLY SIRONA from $35.00 to $33.00 and set a “neutral” rating on the stock in a report on Friday, May 3rd. Finally, Leerink Partnrs restated an “outperform” rating on shares of DENTSPLY SIRONA in a research note on Monday, February 26th. Five equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $35.22.

View Our Latest Analysis on XRAY

DENTSPLY SIRONA Price Performance

XRAY stock opened at $28.04 on Tuesday. The company has a current ratio of 1.43, a quick ratio of 0.97 and a debt-to-equity ratio of 0.54. The company has a market capitalization of $5.82 billion, a P/E ratio of -63.73, a PEG ratio of 1.25 and a beta of 1.04. The business has a 50 day simple moving average of $29.97 and a 200-day simple moving average of $32.45. DENTSPLY SIRONA Inc. has a twelve month low of $26.27 and a twelve month high of $41.65.

DENTSPLY SIRONA (NASDAQ:XRAYGet Free Report) last issued its quarterly earnings data on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.42. DENTSPLY SIRONA had a negative net margin of 2.41% and a positive return on equity of 11.54%. The company had revenue of $953.00 million for the quarter, compared to the consensus estimate of $969.45 million. During the same period last year, the firm posted $0.39 EPS. DENTSPLY SIRONA’s revenue for the quarter was down 2.6% on a year-over-year basis. As a group, equities analysts anticipate that DENTSPLY SIRONA Inc. will post 2.03 EPS for the current year.

DENTSPLY SIRONA Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 12th. Shareholders of record on Friday, June 28th will be given a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, June 28th. This represents a $0.64 dividend on an annualized basis and a yield of 2.28%. DENTSPLY SIRONA’s payout ratio is -145.45%.

Insider Buying and Selling at DENTSPLY SIRONA

In related news, Director Gregory T. Lucier purchased 3,577 shares of the business’s stock in a transaction dated Friday, May 31st. The stock was acquired at an average price of $27.95 per share, for a total transaction of $99,977.15. Following the completion of the purchase, the director now directly owns 58,374 shares of the company’s stock, valued at $1,631,553.30. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 0.52% of the company’s stock.


(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Featured Articles

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.